UiPath (BSP:P2AT34) Research & Development: R$2,041 Mil (TTM As of Apr. 2026)


BSP:P2AT34 UiPath Inc BSP:P2AT34
66 GF Score
Price R$6.78
GF Value R$10.69
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is UiPath Research & Development?

UiPath BSP:P2AT34 +4.79% 66 Research & Development is R$2,041 Mil as of Apr. 2026. GuruFocus rates BSP:P2AT34 with a GF Score™ of 66/100 and a GF Value™ of R$10.69 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. UiPath's Research & Development for the three months ended in Apr. 2026 was R$468 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was R$2,041 Mil.

UiPath  (BSP:P2AT34) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

UiPath Research & Development Related Terms

UiPath Research & Development Historical Data

* Premium members only.

The historical data trend for UiPath's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UiPath Research & Development Chart

UiPath Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Research & Development
Get a 7-Day Free Trial 1,529.91 1,483.67 1,633.34 2,288.24 2,053.78

UiPath Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 549.17 544.14 521.47 507.35 467.66
BSP:P2AT34
66GF Score
UiPath Inc BSP:P2AT34
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UiPath Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$2,041 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R$2,041 Mil mean?
UiPath (BSP:P2AT34) has a Research & Development of R$2,041 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on UiPath and its competitors.
Is UiPath's Research & Development too high?
UiPath's current Research & Development is R$2,041 Mil. Overall, UiPath has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UiPath's Research & Development compare to DBX and ZETA?
UiPath's Research & Development of R$2,041 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on UiPath and its competitors. UiPath's current Research & Development is R$2,041 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UiPath stock overvalued right now?
Based on GuruFocus' analysis, UiPath (BSP:P2AT34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$10.69, compared to a current price of R$6.78 — trading 36.6% below its estimated fair value. The current Research & Development is R$2,041 Mil. UiPath's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For UiPath (BSP:P2AT34), the current Research & Development is R$2,041 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UiPath (BSP:P2AT34) Overvalued in 2026?

Based on GuruFocus' analysis, UiPath stock appears to be undervalued. The current stock price of R$6.78 is trading 36.6% below its estimated GF Value™ of R$10.69. GuruFocus considers UiPath to be Significantly Undervalued.

Key valuation signals for BSP:P2AT34:

  • Research & Development: R$2,041 Mil
  • GF Value™: R$10.69 vs. price of R$6.78 (36.6% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the BSP:P2AT34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UiPath Business Description

Address One Vanderbilt Avenue, 60th Floor, New York, NY, USA, 10017
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.
66GF Score

Get the complete analysis for BSP:P2AT34

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.78
Price
R$10.69
GF Value